Page 76 - Antitrust Division News Today

Principal Deputy Assistant Attorney General Doha Mekki announced US Department of Justice DOJ Antitrust Division was revisiting and withdrawing several policy statements with key safe harbor for certain types of information sharing.

FTC proposed new rule that would prevent employers from entering non-compete agreements with their employees. Non-compete agreements prohibit employees from working for a competing employer or starting a competing business, typically within a set geographic area.

Calling them “outdated” and “overly permissive,” the Department of Justice’s Antitrust Division on February 3, 2023, announced the withdrawal of three long-standing antitrust policy...

Regulatory compliance, medical billing and monopolies made by certificate of need laws have hindered independent doctors from opening and expanding their practices, leading to decreased competition, higher costs and lack of choice for patients.

It has already been a busy 2023 for the U.S. antitrust enforcement agencies.  Right on the heels of the Federal Trade Commission’s announcement of a proposed rule that potentially would...

DOJ Antitrust Division withdraws three antitrust policy statements that established certain safe harbors concerning exchange of data and information among health care providers, citing market changes rendering the prior policy statements out of date.

Calling them outdated, the Department of Justice’s Antitrust Division announced the withdrawal of 3 long standing antitrust policy statements about enforcement in healthcare markets. These policy statements offered federal enforcement insights on healthcare competition issues.

On Feb. 3, 2023, the Department of Justice (DOJ) Antitrust Division announced it was withdrawing three antitrust policy statements relating to enforcement in health care markets due to market changes in the last 30 years rendering the prior policy statements “outdated.”

DOJ Antitrust Division withdrew Department of Justice and FTC Antitrust Enforcement Policy Statements in the Health Care Area, Statements of Antitrust Enforcement Policy in Health Care, Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations

The DOJ withdrew 3 longstanding healthcare antitrust enforcement policy statements. The move follows a series of White House antitrust initiatives. The Biden administration’s purpose for these initiatives is to promote competition and transparency in the healthcare industry.